Yonhap Infomax News6d ago
Lotte Biologics secures CDMO contract with Japan-based global pharmaceutical firm for anticancer drug development and production, aiming to strengthen its competitive position in global biopharmaceutical markets including Japan through enhanced collaborative partnerships.
#YonhapInfomax #LotteBiologics #CDMO #AnticancerDrug #GlobalPharmaceutical #BiopharmaceuticalDevelopment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=113881
Lotte Biologics Signs CDMO Deal with Japan-Based Global Pharma for Cancer Drug

Lotte Biologics secures CDMO contract with Japan-based global pharmaceutical firm for anticancer drug development and production, aiming to strengthen its competitive position in global biopharmaceutical markets including Japan through enhanced collaborative partnerships.

Yonhap Infomax
Yonhap Infomax NewsMay 7, 2025
Chong Kun Dang unveils new corporate identity on 84th anniversary, signaling global ambitions and commitment to innovative healthcare solutions
#YonhapInfomax #ChongKunDang #CorporateIdentity #GlobalPharmaceutical #CompanyAnniversary #HealthcareInnovation #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=61996
Chong Kun Dang Unveils New CI on 84th Anniversary, Aims for Global Pharmaceutical Leadership

Chong Kun Dang unveils new corporate identity on 84th anniversary, signaling global ambitions and commitment to innovative healthcare solutions

Yonhap Infomax